id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0040-0008,FDA,FDA-2010-E-0040,U.S. Patent & Trademark Office to Sanofi-Aventis U.S. Inc. - Letter,Other,Letter(s),2012-07-25T04:00:00Z,2012,7,2012-07-25T04:00:00Z,,2024-11-07T22:43:06Z,,1,0,09000064810b0fed
FDA-2010-E-0040-0007,FDA,FDA-2010-E-0040,FDA/CDER to US Patent and Trademark Office - Letter,Other,Letter(s),2011-08-17T04:00:00Z,2011,8,2011-08-17T04:00:00Z,,2011-08-17T14:45:39Z,,0,0,0900006480ee328d
FDA-2010-E-0040-0006,FDA,FDA-2010-E-0040,Deteermination of Regulatory Review Period for Purposes of Patent Extension; MULTAQ,Notice,N-Notice,2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2010-12-10T16:25:59Z,,0,0,0900006480bb3d90
FDA-2010-E-0040-0005,FDA,FDA-2010-E-0040,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-10-27T04:00:00Z,2010,10,2010-10-27T04:00:00Z,,2010-10-27T15:16:17Z,,0,0,0900006480b789a6
FDA-2010-E-0040-0004,FDA,FDA-2010-E-0040,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-06-18T04:00:00Z,2010,6,2010-06-18T04:00:00Z,,2010-10-29T01:10:41Z,,0,0,0900006480b05c01
FDA-2010-E-0040-0002,FDA,FDA-2010-E-0040,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:04:41Z,,0,0,0900006480a7f6b7
FDA-2010-E-0040-0003,FDA,FDA-2010-E-0040,sanofi-aventis U.S. Inc. - Patent Term Extension Application,Other,APP-Application,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:04:41Z,,0,0,0900006480a7f6b9
FDA-2010-E-0040-0001,FDA,FDA-2010-E-0040,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:10:45Z,,0,0,0900006480ab4d18